Same copper peptide, different depths. Surface-level skincare vs systemic anti-aging — choose your adventure.
Bottom line: Most people should start topical. GHK-Cu serums are accessible, low-risk, and actually work — they beat vitamin C and retinol for collagen stimulation in at least one study. Injectable is the upgrade path for people already comfortable with peptide injections who want systemic effects, but the evidence base is thinner and the copper-balance question is real. Do not inject copper peptides without understanding your baseline copper status.
| GHK-Cu Topical | Injectable | |
|---|---|---|
| Category | Topical copper peptide (serum/cream) | Subcutaneous/intradermal copper peptide injection |
| Mechanism | Penetrates outer skin layers, stimulates collagen and elastin locally, promotes wound healing at the surface | Bypasses skin barrier entirely, reaches deeper dermal layers and systemic circulation for broader tissue remodeling |
| Reported dose | 1–2% concentration in serum, applied 1–2x daily | 1–2 mg subcutaneous, 1–2x weekly |
| Frequency | Daily (morning and/or evening skincare) | 1–2x weekly injection |
| Weight loss (trials) | Not a weight loss peptide | Not a weight loss peptide |
| Top side effect | Mild irritation if overused, potential copper sensitivity in rare cases | Injection site reactions, theoretical risk of copper imbalance with prolonged use, not suitable for Wilson's disease |
| Evidence tier | Tier 2 — outperformed vitamin C and tretinoin for collagen in one study, widely used in cosmetics | Tier 3 — systemic effects extrapolated from topical/wound data, limited human injection studies |
| Common vial size | 15–30 ml serum bottles (cosmetic grade) | 5 mg lyophilized vials |
| Approval status | Available as cosmetic ingredient (not FDA-regulated as drug) | Not FDA-approved. Moved to Category 1 (Feb 2026) |
Topical GHK-Cu is the safe starting point for skin-specific goals — fine lines, skin texture, post-procedure healing, general anti-aging skincare. No needles, no prescription needed, available in most skincare lines. The stratum corneum limits penetration but also limits risk.
Injectable GHK-Cu is for people who want systemic effects — hair growth stimulation, deeper tissue remodeling, whole-body anti-aging signaling. It reaches where topical cannot. But it carries more risk (copper balance, liver considerations) and has less human safety data for this route.
Most people should start topical. GHK-Cu serums are accessible, low-risk, and actually work — they beat vitamin C and retinol for collagen stimulation in at least one study. Injectable is the upgrade path for people already comfortable with peptide injections who want systemic effects, but the evidence base is thinner and the copper-balance question is real. Do not inject copper peptides without understanding your baseline copper status.
← Browse all peptides | All comparisons →
vialprep research · Sources: PubMed, FDA, peer-reviewed trials · How we verify